Cannabis Law Report

JANUARY 16, 2022

Malaysia’s National Pharmaceutical Regulatory Agency (NPRA) previously approved a prescription medicine derived from cannabis in 2014 to treat muscle spasms and spasticity from multiple sclerosis. Sativex was developed by GW Pharmaceuticals, a maker of cannabinoid therapeutics based in Ireland.

Research and Development 98

Research and Development Pharmaceutical Epilepsy Medicine 98

Cannabis Law Report

AUGUST 19, 2021

Industrial hemp is defined as the fibre of the cannabis plant, which is extracted from the stem and is used to produce a variety of industrial and consumer products. 12 Trade Data Analysis (HS Code: 5302). ResearchAndMarkets.com is the world’s leading source for international market research reports and market data.

Hemp 98

Hemp Research and Development Pharmaceutical Data 98

Cannabis Law Report

APRIL 29, 2022

LONDON, April 29, 2022 –( BUSINESS WIRE )–Curaleaf International (the “Company”) part of Curaleaf Holdings (CNSX:CURA), Europe’s largest vertically integrated cannabis company, is pleased to announce the successful license of the Company’s range of cannabis based medicines as extract, under the name Adven, in Malta.

Pharmaceutical 52

Pharmaceutical Medicine Extraction Patients 52

Cannabis Law Report

JUNE 19, 2022

Unlike novel chemical compounds that are synthetically produced in the pharmaceutical industry through drug development programs, psychedelic compounds have a long and established history. As we see more data emerge from clinical trials, we are likely to see patent applications covering stability, pharmacokinetic, and pharmacodynamic data.

Clinical Trials 52

Clinical Trials Microdosing Data Pharmaceutical 52

SpeedWeed

MARCH 9, 2021

ONE of Germany’s largest pharmaceutical firms has entered the medical cannabis space with the launch of a two flower products – and six more products to follow. Hesse-based Stada, Germany’s fifth largest pharmaceutical company, announced late last year it had entered into an agreement with Canadian firm MediPharm Labs.

Chronic Pain 52

Chronic Pain Business Pharmaceutical Extraction 52

Cannabis Law Report

DECEMBER 2, 2021

MW Pharma Limited t/a NUBU Pharmaceuticals. CDC Pharmaceuticals Ltd. CDC Pharmaceuticals Ltd. CDC Pharmaceuticals Ltd. CDC Pharmaceuticals Ltd. Cannabidiol 25 mg/mL equivalent to Cannabis sativa extract 35 mg–42 mg. Tetrahydrocannabinol 27 mg/mL equivalent to Cannabis sativa extract 38 mg–44 mg.

Medicine 52

Medicine Pharmaceutical Sativa THC 52

Freedom Leaf

OCTOBER 15, 2018

On September 28, the DEA designated Epidiolex —a plant-based CBD pharmaceutical manufactured by the UK-based GW Pharmaceuticals—a Schedule V drug in the government’s list of controlled substances. Frontier Data predicts total sales of all CBD products in the U.S. Frontier Data predicts total sales of all CBD products in the U.S.

DEA 51

DEA CBD Pharmaceutical Epilepsy 51

Cannabis Law Report

AUGUST 12, 2021

Since 2013, medicinal cannabis has been legalized in the Czech Republic due to the amendment to the Act on pharmaceuticals, otherwise known as Act No. With medical research indicating that using the plant provides significant medical benefits, the Czech Chamber of Deputies suggested a revision to the government’s Act on pharmaceuticals.

Legalization 59

Legalization Pharmaceutical Safety Extraction 59

Cannabis Law Report

NOVEMBER 23, 2021

Psilobrain is committed to our Drug Development Program, with 3 provisional patents and numerous preclinical studies in various stages of research and data collection. and is an active contributor in the pharmaceutical, nutraceutical and psychedelic wellness industries. VANCOUVER, BC , Nov. About HAVN Life Sciences Inc.

Supply Chain 52

Supply Chain Research and Development Pharmaceutical Compliance 52

Cannabis Law Report

DECEMBER 19, 2021

MW Pharma Limited t/a NUBU Pharmaceuticals. CDC Pharmaceuticals Ltd. CDC Pharmaceuticals Ltd. CDC Pharmaceuticals Ltd. CDC Pharmaceuticals Ltd. Cannabidiol 25 mg/mL equivalent to Cannabis sativa extract 35 mg–42 mg. Tetrahydrocannabinol 27 mg/mL equivalent to Cannabis sativa extract 38 mg–44 mg.

Medicine 52

Medicine Pharmaceutical THC Sativa 52

Cannabis Law Report

SEPTEMBER 7, 2021

Despite these considerations, HHC vape carts hit the market without an accredited Certificate of Analysis (COA) or toxicity data. President and CSO of Delic Labs, about side reactions in extracts, such as the formation of CBN. Dr. Roggen noted that you do not have reducing environments in normal extraction techniques.

THC 93

THC Cannabinoids Digestion Data 93

Cannabis Law Report

JULY 12, 2021

Pure Extracts Inc. Algernon Pharmaceuticals Inc. CSE: MSET) revealed additional preclinical data showing strong efficacy and improved safety in a head-to-head comparison with psilocybin. Weekly Performance: $133.19 (-1.61%). Powered by. CFN Enterprises Inc. OTCQB: CNFN). Top Gainers. CSE: PULL). 0.385 +0.155 (67.39%).

Treatment 66

Treatment Decriminalization Pharmaceutical Data 66

Cannabis Law Report

MARCH 17, 2022

Cannabis extracts or strains are from herbal cannabis plants. If any weed company fails to compose all of this data on their product label, it may not be legal and doesn’t possess high quality. However, sadly, there are not enough restrictions that regulate the manufacturing method of cannabis extracts. Source Of The CBD Strain.

CBD 52

CBD Extraction Cannabinoids Strains 52

The Cannigma

JUNE 15, 2021

However, the scientific data on CBG is nowhere near as developed as what we have on CBD. The vast majority of what we know about CBD’s medicinal effects is based on laboratory studies, is far from being properly understood, and lacks solid scientific data on human subjects — aside from epilepsy 5.

CBD 122

CBD Research and Development Epilepsy Extraction 122

Project CBD

JANUARY 25, 2023

The scientists also tested the lipid-lowering drug on skeletal muscle tissue, which they extracted from sacrificed mice, and on human myoblasts. A peer-reviewed article, based on the data discussed in a preprint, was subsequently published in Nature. Peer-reviewed article on statins and endocannabinoid function.

Cannabinoids 130

Cannabinoids Patients Data Extraction 130

Cannabis Law Report

DECEMBER 15, 2021

Pharmaceuticals & Medical Devices. Cann Group has established a leading position in plant genetics, breeding, extraction, analysis and production techniques required to facilitate the supply of medicinal cannabis for a range of diseases and medical conditions. Senior Regulatory Affairs Associate. Cann Group Limited. Posted 2d ago.

Research and Development 52

Research and Development Pharmaceutical Compliance Compliance 52

Cannabis Law Report

AUGUST 11, 2021

Avicanna is a diversified and vertically integrated Canadian biopharmaceutical company focused on the research, development and commercialization of plant-derived cannabinoid-based products for the global consumer, medical, and pharmaceutical market segments. They are a great strategic fit. and Santa Marta Golden Hemp S.A.S.,

Topical 98

Topical Research and Development Seed-To-Sale Pharmaceutical 98

Cannabis Law Report

MARCH 9, 2022

Pharmaceuticals & Medical Devices. Cann Group has established a leading position in plant genetics, breeding, extraction, analysis and production techniques required to facilitate the supply of medicinal cannabis for a range of diseases and medical conditions. Senior Regulatory Affairs Associate. Cann Group Limited. Posted 1d ago.

Research and Development 52

Research and Development Pharmaceutical Compliance Compliance 52

Cannabis Law Report

NOVEMBER 22, 2019

MMJ International Holdings is developing oral drug products from natural whole plant extract derivatives from the marijuana plant containing THC and CBD. MMJ is confident that their pharmaceutical drugs will bring much needed relief to patients suffering from the debilitating effects of Multiple Sclerosis and Huntington’s Disease.

DEA 66

DEA Clinical Trials THC Research and Development 66

Cannabis Law Report

AUGUST 14, 2021

Mary AG’s joint venture Yunnan Moquan and CBDer are currently the only companies licensed for indoor industrial hemp cultivation in China’s only legalized province for cannabinoid extraction. The MOU mainly encompasses: Working with CBDer to further develop China’s industrial hemp market. About Mary Agrotechnologies Inc.

Hemp 105

Hemp Supply Chain Cannabinoids Extraction 105

Cannabis Law Report

SEPTEMBER 12, 2022

Our mushrooms are some of the most tested products on the planet as we cross the lines between Pharmaceutical, Agriculture, Botanical, and Food testing quality assays,” said Optimi Chief Science Officer, Justin Kirkland.

History 52

History Clinical Trials Legalization Research and Development 52

The Cannigma

JULY 1, 2022

Research funding is also up, and all of this data influences how we see, think and hear about the plant and its effects. Additionally, there are misleading practices of “p-hacking” where researchers can manipulate data through different statistical tests (thanks to modern computer programs) looking for statistically significant findings.

Research and Development 108

Research and Development Data THC Clinical Trials 108

SpeedWeed

MARCH 7, 2021

Mark does have quite a bit to share with us, but as always, we’re going to check in with Ed to see what he’s uncovered this week from the data vault. This one was on the advisory sector, which focuses on consultants as well as essentially data analytics firms, so that was fun to dig back into that. Is it a VAR channel?

Extraction 52

Extraction Data Hemp Research and Development 52

Cannabis Law Report

JUNE 24, 2021

By End-user, the market is classified as Medical, Pharmaceutical, Wellness, and Others. The report includes in-depth qualitative analysis, verifiable data from authentic sources, and projections about market size. Increasing Preference towards Cannabis Extracts such as Oils and Tinctures. GW Pharmaceuticals, plc.

Research and Development 78

Research and Development Tincture Chronic Pain Pharmaceutical 78

Veriheal

DECEMBER 28, 2021

This is according to recent data from a report published by Market Research Future (MRT) – a pioneer in market analysis. For example, pharmaceutical-grade cannabis is being sold across the fast-evolving retail pharmacy landscape. by the year 2027 , at which point the market could be worth a staggering $33.2

Research and Development 98

Research and Development Chronic Pain Treatment Medicine 98

Cannabis Law Report

JANUARY 11, 2019

“Nevertheless, many companies with CBD products in their portfolio were surprised when the Ministry issued a decree stipulating the handling of extracts containing cannabinoids.”. According to official government data, more than 20 percent of Austria’s 8.77 Then again, not all ingredients containing CDB are novel.

Seed-To-Sale 49

Seed-To-Sale Food Hemp Oil 49

Cannabis Law Report

JULY 6, 2021

Dr. Bankole Johnson was also the founder of NASDAQ listed Adial Pharmaceuticals (NASDAQ: ADIL) and currently serves as its Chief Medical Officer. Johnson has also been presented with the prestigious Jack Mendelson Award from the NIAAA and the Solomon Carter Fuller Award by the American Psychiatric Association.

Research and Development 97

Research and Development Wellness and Beauty Clinical Trials Therapy 97

Cannabis Law Report

DECEMBER 1, 2019

MHA, without elaborating on the girl’s age, the specific medication and her current condition, said: “Given the patient’s condition, her doctor applied to the Health Sciences Authority (HSA) to bring in a cannabinoid pharmaceutical, considering that the treatment might address the unmet medical need.”.

Epilepsy 59

Epilepsy Cannabinoids Therapy Treatment 59

The Joint Blog

NOVEMBER 2, 2020

According to a new study published in the Journal of Pharmacy & Pharmaceutical Sciences, using marijuana as an adjunct treatment for Huntington disease (HD) is both effective and safe. Study selection, quality assessment and data extraction was performed by three reviewers.

Treatment 37

Treatment Sleep Marijuana Patients 37

Cannabis Law Report

OCTOBER 15, 2019

The medical cannabis industry is coming to Brazil beyond imports of pharmaceutical-based cannabis medicines. . Brazil is currently a leading importer of pharmaceutical-based cannabis medicine. Pharmaceutical-based cannabis products are not effective for a large number of suffering patients in Brazil.

Pharmaceutical 40

Pharmaceutical Sativa Topical Cultivation 40

SpeedWeed

AUGUST 19, 2021

In 1978, DEA agents discovered a clandestine lab in Jacksonville, Florida, had combined a cannabis extract with acetic anhydride. The process involves a series of extractions that begin with hemp, the low-THC cannabis plant that was made federally legal by Congress in the 2018 farm bill. First, CBD is extracted from raw hemp.

THC 52

THC Hemp Extraction Vaping 52

Cannabis Law Report

JANUARY 10, 2022

For instance, as of June 2021, InMed Pharmaceuticals, Inc., List To Data Sources. Zero Point Extraction. This high share is attributable to the increasing utilization of minor cannabinoid-based products for such conditions and rising research for signifying their benefits in improving health. Market Segmentation and Scope.

Cannabinoids 52

Cannabinoids Clinical Trials Research and Development Supply Chain 52

Cannabis Info

MARCH 2, 2019

We briefly reviewed some of the history, preclinical and clinical data, and controversies surrounding the use of medical marijuana for the treatment of epilepsy, and make a case that the desire to isolate and treat with pharmaceutical grade compounds from cannabis (specifically CBD) may be inferior to therapy with whole plant extracts”.

Epilepsy 69

Epilepsy Treatment Marijuana Research and Development 69

The Cannigma

OCTOBER 9, 2021

An open-label pilot study of cannabis extracts for bladder dysfunction in patients with multiple sclerosis demonstrated a significant decrease in urinary symptoms including urgency, frequency, the number and volume of episodes of incontinence, as well as nightly awakenings to use the bathroom (Brady, 2004).

Cannabinoids 86

Cannabinoids Consumption Patients Cannabis 86

Cannabis Law Report

OCTOBER 12, 2021

d/b/a Venom Extracts (“ Venom Extracts “) which transformed the Company into a multi-state operator and substantially enhanced its revenue, capabilities and reach. Jake is the founder of Venom Extracts, one of the industry’s premier award-winning cannabis concentrate brands. I’m humbled and excited to take on this challenge.

Extraction 52

Extraction Business Hash Events 52

Cannabis Law Report

SEPTEMBER 15, 2021

Total retail sales in Missouri are expected to grow to USD$650 million by 2025 per New Frontier Data. We are seeing strong demand for our brands in Canada and with our extraction expertise and inspired branding capabilities, we expect to see a similar response in Missouri and additional states as we continue our U.S. expansion.”.

Events 52

Events Dispensary Extraction Cannabis 52

CannaTech

OCTOBER 14, 2018

The bill, scheduled to take effect on January 1, 2019, allows California farmers to enter the rapidly-growing hemp industry on a wide scale, raising industrial hemp to produce hemp seed, oil, fiber, and extract for a variety of uses. billion by 2022, according to New Frontier Data, a premier cannabis data analytics firm.

Hemp 53

Hemp Research and Development Agriculture Seed-To-Sale 53